{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:38:41Z","timestamp":1782401921809,"version":"3.54.5"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,11,15]]},"DOI":"10.2169\/internalmedicine.5218-24","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T18:07:16Z","timestamp":1747246036000},"page":"3272-3278","source":"Crossref","is-referenced-by-count":2,"title":["Cisplatin-induced Severe Renal Salt-wasting Syndrome Complicated with Hypovolemic Shock and Various Electrolyte Abnormalities in a Patient with Thymoma"],"prefix":"10.2169","volume":"64","author":[{"given":"Takatsune","family":"Hosoya","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyofumi","family":"Shimoji","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kakuhiro","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinjiro","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Horimasu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Hamada","sequence":"additional","affiliation":[{"name":"Department of Physical Analysis and Therapeutic Sciences, Hiroshima University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Volarevic V, Djokovic B, Jankovic MG, et al. Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity. J Biomed Sci 26: 25, 2019.","DOI":"10.1186\/s12929-019-0518-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hutchison FN, Perez EA, Gandara DR, Lawrence HJ, Kaysen GA. Renal salt wasting in patients treated with cisplatin. Ann Intern Med 108: 21-25, 1988.","DOI":"10.7326\/0003-4819-108-1-21"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hamdi T, Latta S, Jallad B, Kheir F, Alhosaini MN, Patel A. Cisplatin-induced renal salt wasting syndrome. South Med J 103: 793-799, 2010.","DOI":"10.1097\/SMJ.0b013e3181e63682"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Jinsi N, Vimala A, Nair SS, Arya RJ, Ravi R. Renal salt-wasting syndrome induced by neoadjuvant chemotherapy containing cisplatin - a case report. Indian J Nephrol 32: 76-78, 2022.","DOI":"10.4103\/ijn.IJN_247_19"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Pham PC, Reddy P, Qaqish S, et al. Cisplatin-induced renal salt wasting requiring over 12 liters of 3% saline replacement. Case Rep Nephrol 2017: 8137078, 2017.","DOI":"10.1155\/2017\/8137078"},{"key":"6","unstructured":"6. Suzuki H, Hirashima T, Kobayashi M, et al. Renal salt-wasting syndrome progressing to severe hyponatremia after chemotherapy - a case report. Gan To Kagaku Ryoho (Jpn J Cancer Chemother) 37: 543-546, 2010 (in Japanese, Abstract in English)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hatakeyama S, Shida T, Yamaguchi H. Risk factors for severe hyponatremia related to cisplatin: a retrospective case-control study. Biol Pharm Bull 42: 1891-1897, 2019.","DOI":"10.1248\/bpb.b19-00477"},{"key":"8","unstructured":"8. Yajima Y, Fujii M, Tokumaru Y, Habu N. Hyponatremia with cisplatin administration in head and neck cancer patients. Gan To Kagaku Ryoho (Jpn J Cancer Chemother) 37: 2861-2865, 2010 (in Japanese, Abstract in English)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yeoh KW, Camilleri P, Patel K. Chemotherapy induced Hyponatraemia. BMJ Case Rep 2010 bcr05.2009.1920.","DOI":"10.1136\/bcr.05.2009.1920"},{"key":"10","unstructured":"10. Ohtaka M, Hattori Y, Kumano Y, et al. Severe hyponatremia after cisplatin-based chemotherapy: two case reports. Hinyokika Kiyo (Acta Urol Jpn) 62: 361-366, 2016 (in Japanese, Abstract in English)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Fujishiro H, Taguchi H, Hamao S, Sumi D, Himeno S. Comparisons of segment-specific toxicity of platinum-based agents and cadmium using S1, S2, and S3 cells derived from mouse kidney proximal tubules. Toxicol In Vitro 75: 105179, 2021.","DOI":"10.1016\/j.tiv.2021.105179"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kishore BK, Krane CM, Di Iulio D, Menon AG, Cacini W. Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria. Kidney Int 58: 701-711, 2000.","DOI":"10.1046\/j.1523-1755.2000.00216.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Soares AG, Mironova E, Archer CR, Contreras J, Stockand JD, Abd El-Aziz TM. Cisplatin decreases ENaC activity contributing to renal salt wasting syndrome. Cancers (Basel) 12: 2140, 2020.","DOI":"10.3390\/cancers12082140"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Verzicco I, Regolisti G, Quaini F, et al. Electrolyte disorders induced by antineoplastic drugs. Front Oncol 10: 779, 2020.","DOI":"10.3389\/fonc.2020.00779"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ledeganck KJ, Boulet GA, Bogers JJ, Verpooten GA, De Winter BY. The TRPM6\/EGF pathway is downregulated in a rat model of cisplatin nephrotoxicity. PLoS One 8: e57016, 2013.","DOI":"10.1371\/journal.pone.0057016"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol 18: 2649-2652, 2007.","DOI":"10.1681\/ASN.2007070792"},{"key":"17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2407-6-128","volume":"6","author":"K Hoffmann","year":"2006","unstructured":"17. Hoffmann K, Marten A, Lindel K, et al. Major combined electrolyte deficiency during therapy with low-dose cisplatin, 5-fluorouracil and interferon alpha: report on several cases and review of the literature [ISRCTN62866759]. BMC Cancer 6: 128, 2006.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Liamis G, Milionis HJ, Elisaf M. A review of drug-induced hypocalcemia. J Bone Miner Metab 27: 635-642, 2009.","DOI":"10.1007\/s00774-009-0119-x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Iyer AV, Krasnow SH, Dufour DR, Arcenas AS. Sodium-wasting nephropathy caused by cisplatin in a patient with small-cell lung cancer. Clin Lung Cancer 5: 187-189, 2003.","DOI":"10.3816\/CLC.2003.n.033"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Tscherning C, Rubie H, Chancholle A, et al. Recurrent renal salt wasting in a child treated with carboplatin and etoposide. Cancer 73: 1761-1763, 1994.","DOI":"10.1002\/1097-0142(19940315)73:6<1761::AID-CNCR2820730635>3.0.CO;2-#"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/22\/64_5218-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T03:27:28Z","timestamp":1763177248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/22\/64_5218-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":20,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5218-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,15]]},"article-number":"5218-24"}}